Abiopharma

🔍 Liuzza Nicholas Reyland JR (Director)

Company: Red Cat Holdings, Inc. (RCAT)

Report Date: 2026-08-11

Detailed Transactions and Holdings:

• Sold 55,000 shares of Common Stock at $10.63 per share (Direct)
  Date: 2026-08-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 489,874.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.60 to $10.66, inclusive. The reporting person undertakes to provide Red Cat Holdings, Inc., any security holder of Red Cat Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.